Basic Science Reception | Connect with investigators, trainees, and leaders to share ideas, build collaborations, and celebrate innovation in endocrinology. Join us 6:00–7:30 PM in Room W181 Foyer for an inspiring evening. #ENDO2026
Nelson Lab, UIUC
@nelsonlab.bsky.social
We investigate how hormones and metabolic factors impact tumor progression. Our goal is to use this information to develop novel therapeutics for the treatment.
Our Annual Meeting Steering Committee, the dedicated group responsible for designing the educational, clinical, and scientific programming, shares what they are most excited about for #ENDO2026. #endocrinology #hormonescience
ENDO 2026: Know Before You Go | ENDO is only a day away! Prepare to make the most of the meeting by reviewing key resources that will be available to you: bit.ly/4awV3c3 #ENDO20206
Erik R. Nelson, PhD, #ENDO2026 Annual Committee Basic Science Chair, shares program highlights for researchers—from discovery to networking. Join us in Chicago, June 13–16, to connect bench to bedside and back:https://bit.ly/4wNkvDT
ENDO 2026 for Basic Scientists | Erik R. Nelson, PhD
Erik R. Nelson, ENDO 2026 Annual Committee Basic Science Chair, shares program highlights for from sessions featuring prominent researchers to networking opportunities. Join us in Chicago, IL, US, June 13–16, for the latest research and connections fro...
bit.ly
More science. More networking. More to explore. Register for #ENDO2026 expanded basic science and clinical sessions, and events like the International Welcome Reception, 5K Fun Run/Walk, and ENDOExpo with 100+ exhibitors. June 13–16, Chicago https://bit.ly/49iHgoX #endocrinology
Gisella Carranza Leon, MD, #ENDO2026 Annual Meeting Chair, shares program highlights and what she’s most excited for at ENDO, taking place June 13–16. Discover how ENDO can help your goals, networking and more: https://bit.ly/4ndcq6X #endocrinology #EndoSky
ENDO 2026: Sessions for Everyone with Gisella Carranza Leon, MD
Gisella Carranza Leon, MD, ENDO 2026 Annual Meeting Chair, shares program highlights and what she’s most excited for at ENDO 2026, taking place June 13–16: https://bit.ly/3RkyDUx She covers how we have sessions for everyone, no matter their study or ca...
bit.ly
Big News. Today the Cancer Center at Illinois becomes the 8th NCI Designated Basic Cancer Center. www.cancer.gov/research/inf...
The deadline to submit your late-breaking abstracts for #ENDO2026 is Tuesday, April 21! This is your opportunity to connect with leading investigators, gain valuable exposure for your work, and help advance the science that drives better patient care: bit.ly/4sF4zAY
ENDO 2026: Late-Breaking Abstracts Now Open | Submit your late-breaking abstract for presentation at ENDO by Tuesday, April 21 at 1:00 PM ET: bit.ly/4sF4zAY #ENDO2026 #endocrinology #hormonescience
ENDO 2026: Late-Breaking Abstracts Now Open | Submit your late-breaking abstract for presentation at ENDO by Tuesday, April 21 at 1:00 PM ET: bit.ly/4sF4zAY #ENDO2026 #endocrinology #hormonescience
Register now for an amazing menu of endocine-related science and clinical practice! Early bird rate is ending soon! #ENDO2026
Hurry! Only A Few Hours Left to Take Advantage of Lowest #ENDO2026 Rates | Register by tonight at 11:59 PM ET to receive the best rates. Don’t miss out! Join us at ENDO for an unforgettable experience of science, connection, and discovery: bit.ly/3Zn1sR9 #endocrinology #EndoSky
ENDO 2026 Early Registration Is Now Open | Join us in Chicago, IL, US for thought-provoking sessions and discussions on the latest in hormone health and science. Secure the lowest rates (bit.ly/4awLVUd) and watch our video (bit.ly/4kByPcY) #ENDO2026 #endocrinology #EndoSky
ENDO2026 has an amazing lineup! The best of basic, translational and clinical sciences. Don't miss out!
#ENDO2026 Abstract Submissions Are Now Open | Share your research to earn media coverage for your work. Accepted abstracts may be published in a supplement to our Open Access publication, #JES. The deadline is Thursday, January 15: https://bit.ly/49lxDqp #EndoSky @endosocjournals.bsky.social
New paper from the Nelson Lab! ABCA1 activity re-educates macrophages to being anti-cancer. Science Advances Paper here: www.science.org/doi/10.1126/...
Cholesterol efflux protein, ABCA1, supports anticancer functions of myeloid immune cells
Cholesterol efflux protein ABCA1 shifts macrophages to being anticancer, highlighting its potential use as a therapeutic target.
science.org
ENDO 2026 Travel Grants Expanded | To support our research and early career communities, we are thrilled to announce a one-year expansion of our ENDO 2026 travel grant programs. This expansion will provide heightened support to more researchers. Learn more: https://bit.ly/4pvLqPA #ENDO2026
Our ENDO 2026 Plenary Lineup | We are excited to announce the ENDO Plenaries! Watch our president, Carol Lange, PhD, announce the distinguished plenary speakers and what they will be exploring at ENDO 2026: bit.ly/3MpRMlK #ENDO2026 #endocrinology #EndoSky
ENDO 2026 Plenary Lineup
We are excited to announce the ENDO 2026 Plenaries! Taking place June 13-16, 2026, in Chicago, IL, USA, ENDO will bring together world-renowned speakers to showcase the latest developments in hormone science and medicine. Hear our president, Carol Lange, PhD, announce the distinguished plenary speakers and what they will be exploring at ENDO 2026. Learn more: https://bit.ly/4pknKyl Plenary sessions include: • Unraveling Hormonal Complexity: Genomics, Sex Differences, and Physiology • Metabolism in Motion: Endocrine Regulation as a Launchpad for Therapeutic Innovation • Molecular Mechanisms in Hormone Signaling: From Bench to Bedside
bit.ly
#ENDO2026 Abstract Submitters: The deadline for our Outstanding Abstract Awards is Thursday, January 15. Select the Outstanding Abstract Awards option during abstract submission to apply. Learn more: https://bit.ly/49lxDqp #endocrinology
Call for Abstracts
ENDO 2026 Call for Abstracts
bit.ly
The latest paper from our group is now out! Extracelluar vesicles from neutrophils drive breast cancer cells towards being more stem-like; important consequences for chemotherapy. News story and summary here: cancer.illinois.edu/researchers-... . Publication found here: doi.org/10.1016/j.ca... .
Researchers Aim to Disrupt Breast Cancer Line of Communication and Prevent Spread | Cancer Center at Illinois
cancer.illinois.edu
Join the CCIL Cancer Research Advocacy Group for an online seminar focused on supporting mental health during a cancer diagnosis. Strategies for coping and finding empowerment through the journey - from an oncology counselor and survivors' perspectives. forms.illinois.edu/sec/50084012...
Watch our videos with Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, on creation of ENDO programming and how submitting a session idea can help you in your career. She provides insight in English (bit.ly/3UOXNJB) and Español (bit.ly/47RuYUz). #ENDO2026 #endocrinology
Gisella Carranza Leon, MD | ENDO 2026 Session Submissions
Annual Meeting Steering Committee Chair (AMSC) Gisella Carranza Leon, MD, discusses how submitting a session idea can help you in your career. She also provides insight on how the AMSC uses session ideas to create ENDO programming. Submit your session suggestions and symposia proposals by Tuesday, September 2: https://bit.ly/4flCMjl #ENDO2026
bit.ly
What were your favorite articles in the current issue of @endocrinenews.bsky.social? Our cover story interviews Erik Nelson, PhD. Our features explore diabetes and liver disease and a Q&A C. Wayne Bardin International Travel Award Winner Yoshitomo Hoshino, MD, PhD. Read more: https://bit.ly/3UZMPkw
Help shape ENDO2026! Submit your suggestions for great endocrine society science now!
Help Shape the Education Program for ENDO 2026 | Share what you want to see at ENDO 2026, taking place June 13–16 in Chicago, IL. Whether you have a fully developed session in mind or just a seed of an idea, your input is welcome and appreciated: bit.ly/4flCMjl #ENDO2026 #endocrinology
My amazing colleague @loriraetzman.bsky.social the 2025 Endoctrine Society Laureate Awardee for distinguished service. #ENDO2025 @endocrinesociety.bsky.social
Some amazing programming about to happen at #ENDO2025 !! @endocrinesociety.bsky.social
Heading off to #ENDO2025 @endocrinesociety.bsky.social If you’ll be there and are interested in cancer and the microbiome-please stop by our session SY16 Saturday at 4:30!
#Illinois researchers have successfully treated a common type of colorectal cancer tumor with a cholesterol inhibitor drug, demonstrating a promising treatment for the disease in animal experiments. The study was published in Nature Chemical Biology: go.mcb.illinois.edu/623 @nelsonlab.bsky.social
Colorectal cancer treated with cholesterol inhibitor in U. of I. study | School of Molecular & Cellular Biology | Illinois
University of Illinois researchers have successfully treated a common type of colorectal cancer tumor with a cholesterol inhibitor drug, demonstrating a promising treatment for the disease in animal experiments.
mcb.illinois.edu
I am very proud to have helped develop Elacestrant for the treatment of breast cancer. There is still much to be done - and we show up to lab every day striving to do better for patients. Stories like these inspire us: www.youtube.com/watch?v=Puk6... #endcancer #BCSM #breastcancer #stage4
Research at Duke Restored Mei's Quality of Life
YouTube video by Duke University
youtube.com
New review paper from the lab highlighting cholesterol, the immune system and tumor biology. PhD co-authors discuss its importance in this interview.
Current treatment options for metastatic breast cancer are limited, but targeting cholesterol metabolism is a promising option for new therapeutics. go.mcb.illinois.edu/cholesterol
Just a day away! Join the Cancer Research Advocacy Group for a special webinar on survivorship. Great tips on navigating the insurance system! Register here: forms.illinois.edu/sec/380306938